The Effect of Low Carbohydrate Diet on Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials

被引:46
|
作者
Zhang, Xiaoshuai [1 ]
Zheng, Yang [1 ]
Guo, Yanan [1 ]
Lai, Zhiwen [2 ]
机构
[1] Chongqing Med Univ, 1 Med Coll Rd, Chongqing 400010, Peoples R China
[2] Chengdu Xinan Gynecol Hosp, Dept Gynecol, Chengdu, Sichuan, Peoples R China
关键词
HYPOCALORIC DIET; HIGH-PROTEIN; WOMEN; MANAGEMENT; STIMULATION; OVERWEIGHT;
D O I
10.1155/2019/4386401
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To assess the effect of a low carbohydrate diet (LCD) on women with polycystic ovary syndrome (PCOS). Methods. Data from randomized controlled trials (RCTs) were obtained to perform a meta-analysis of the effects of LCD in PCOS patients. The primary outcomes included the changes in BMI, homeostatic model assessment for insulin resistance (HOMA-IR), and blood lipids, including total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C), follicle-stimulating hormone (FSH), luteotropic hormone (LH), total testosterone (T), and sex hormone-binding globulin (SHBG). Results. Eight RCTs involving 327 patients were included. In comparison with the control group, the LCD decreased BMI (SMD = -1.04, 95% CI (-1.38, -0.70), P<0.00001), HOMA-IR (SMD = -0.66, 95% CI (-1.01, -0.30), P<0.05), TC (SMD = -0.68, 95% CI (-1.35, -0.02), P<0.05), and LDL-C (SMD = -0.66, 95% CI (-1.30, -0.02), P<0.05). Stratified analyses indicated that LCD lasting longer than 4 weeks had a stronger effect on increasing FSH levels (MD = 0.39, 95% CI (0.08, 0.71), P<0.05), increasing SHBG levels (MD = 5.98, 95% CI (3.51, 8.46), P<0.05), and decreasing T levels (SMD = -1.79, 95% CI (-3.22, -0.36), P<0.05), and the low-fat and low-CHO LCD (fat <35% and CHO <45%) had a more significant effect on the levels of FSH (MD = 0.40, 95% CI (0.09, 0.71), P<0.05) and SHBG (MD = 6.20, 95% CI (3.68, 8.72), P<0.05) than the high-fat and low-CHO LCD (fat >35% and CHO <45%). Conclusion. Based on the current evidence, LCD, particularly long-term LCD and low-fat/low-CHO LCD, may be recommended for the reduction of BMI, treatment of PCOS with insulin resistance, prevention of high LDL-C, increasing the levels of FSH and SHBG, and decreasing the level of T level. Together, the analyzed data indicate that proper control of carbohydrate intake provides beneficial effects on some aspects of PCOS and may represent one of the important interventions improving the clinical symptoms of affected patients.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Effects of polyphenol in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials
    Balieiro, Caroline Cristine Almeida
    Hespanhol, Larissa C.
    Fonseca, Luiza Mendes
    Wantowski, Sabrina
    Freitas, Marcos A. A.
    Dias, Yasmin J. M.
    Burla, Marina M.
    de Oliveira, Lilia Maria Lima
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 294 : 84 - 91
  • [22] Effects of Sitagliptin on Metabolic Indices and Hormone Levels in Polycystic Ovary Syndrome: a Meta-analysis of Randomized Controlled Trials
    Lijuan Zhang
    Airong Chen
    Jing Lu
    Liuliu Ren
    Zelin Hu
    Reproductive Sciences, 2023, 30 : 1065 - 1073
  • [23] The effects of statins on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
    Jianguo Chen
    Chaoran Huang
    Tongtong Zhang
    Wuqing Gong
    Xiaofeng Deng
    Hua Liu
    Jinbo Liu
    Yuanbiao Guo
    Reproductive Biology and Endocrinology, 19
  • [24] The effects of statins on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
    Chen, Jianguo
    Huang, Chaoran
    Zhang, Tongtong
    Gong, Wuqing
    Deng, Xiaofeng
    Liu, Hua
    Liu, Jinbo
    Guo, Yuanbiao
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2021, 19 (01)
  • [25] The Effectiveness and Safety of Exenatide Versus Metformin in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials
    Zheng-Rong Ye
    Can-Qun Yan
    Nianchun Liao
    Si-Hua Wen
    Reproductive Sciences, 2023, 30 : 2349 - 2361
  • [26] Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
    Greff, Dorina
    Juhasz, Anna E. E.
    Vancsa, Szilard
    Varadi, Alex
    Sipos, Zoltan
    Szinte, Julia
    Park, Sunjune
    Hegyi, Peter
    Nyirady, Peter
    Acs, Nandor
    Varbiro, Szabolcs
    Horvath, Eszter M. M.
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2023, 21 (01)
  • [27] Effects of Sitagliptin on Metabolic Indices and Hormone Levels in Polycystic Ovary Syndrome: a Meta-analysis of Randomized Controlled Trials
    Zhang, Lijuan
    Chen, Airong
    Lu, Jing
    Ren, Liuliu
    Hu, Zelin
    REPRODUCTIVE SCIENCES, 2023, 30 (04) : 1065 - 1073
  • [28] Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
    Dorina Greff
    Anna E. Juhász
    Szilárd Váncsa
    Alex Váradi
    Zoltán Sipos
    Julia Szinte
    Sunjune Park
    Péter Hegyi
    Péter Nyirády
    Nándor Ács
    Szabolcs Várbíró
    Eszter M. Horváth
    Reproductive Biology and Endocrinology, 21
  • [29] The Effectiveness and Safety of Exenatide Versus Metformin in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials
    Ye, Zheng-Rong
    Yan, Can-Qun
    Liao, Nianchun
    Wen, Si-Hua
    REPRODUCTIVE SCIENCES, 2023, 30 (08) : 2349 - 2361
  • [30] N-Acetylcysteine for Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
    Thakker, Divyesh
    Raval, Amit
    Patel, Isha
    Walia, Rama
    OBSTETRICS AND GYNECOLOGY INTERNATIONAL, 2015, 2015